Correction to: CD200 Immune-Checkpoint Peptide Elicits an Anti-glioma Response Through the DAP10 Signaling Pathway (Neurotherapeutics, (2021), 10.1007/s13311-021-01038-1)

Elisabet Ampudia-Mesias, Francisco Puerta-Martinez, Miurel Bridges, David Zellmer, Andrew Janeiro, Matt Strokes, Yuk Y. Sham, Ayman Taher, Maria G. Castro, Christopher L. Moertel, G. Elizabeth Pluhar, Michael R. Olin

Research output: Contribution to journalComment/debatepeer-review

Abstract

This erratum is to update a co-author’s name. Maria Castro will be updated to appear as Maria G. Castro. The original article has been corrected.

Original languageEnglish (US)
JournalNeurotherapeutics
DOIs
StateAccepted/In press - 2021

Bibliographical note

Publisher Copyright:
© 2021, The American Society for Experimental NeuroTherapeutics, Inc.

PubMed: MeSH publication types

  • Published Erratum

Fingerprint

Dive into the research topics of 'Correction to: CD200 Immune-Checkpoint Peptide Elicits an Anti-glioma Response Through the DAP10 Signaling Pathway (Neurotherapeutics, (2021), 10.1007/s13311-021-01038-1)'. Together they form a unique fingerprint.

Cite this